{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:08:47Z","timestamp":1790356127859,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council of Taiwan","doi-asserted-by":"crossref","award":["NSC 99-2628-B-002-040-MY3"],"award-info":[{"award-number":["NSC 99-2628-B-002-040-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008108","name":"Taipei Tzu Chi General Hospital","doi-asserted-by":"crossref","award":["TCRD-TPE-95-33"],"award-info":[{"award-number":["TCRD-TPE-95-33"]}],"id":[{"id":"10.13039\/501100008108","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neuropharm.2012.11.031","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T09:03:56Z","timestamp":1354957436000},"page":"412-418","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Acetazolamide impairs fear memory consolidation in rodents"],"prefix":"10.1016","volume":"67","author":[{"given":"Ming-Tao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lin","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-Hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houng-Chi","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Mei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.11.031_bib1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/01.wnl.0000238099.36998.6b","article-title":"Effect of topiramate on cognition in obese children","volume":"67","author":"Aarsen","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.physbeh.2011.07.026","article-title":"Maternal dietary loads of alpha-tocopherol differentially influence fear conditioning and spatial learning in adult offspring","volume":"104","author":"Ambrogini","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib4","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1345\/aph.1P163","article-title":"Treatment of civilian and combat-related posttraumatic stress disorder with topiramate","volume":"44","author":"Andrus","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib5","first-page":"35","article-title":"Startle responses to electric shocks: measurement of shock sensitivity and effects of morphine, buspirone and brain lesions","volume":"43","author":"Chen","year":"2000","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib6","first-page":"75","article-title":"Amphetamine induced sensitization in acoustic startle: lack of blockade by adrenalectomy and alpha-helical CRF9-41","volume":"45","author":"Chen","year":"2002","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nn1482","article-title":"PI3 kinase signaling is required for retrieval and extinction of contextual memory","volume":"8","author":"Chen","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2008.06.040","article-title":"Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1","volume":"590","author":"Chien","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0166-4328(98)00054-0","article-title":"Ibotenate lesions of the hippocampus impair spatial learning but not contextual fear conditioning in mice","volume":"98","author":"Cho","year":"1998","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002130100766","article-title":"Effects of high-affinity GABA B receptor antagonists on active and passive avoidance responding in rodents with gamma-hydroxybutyrolactone-induced absence syndrome","volume":"157","author":"Getova","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib11","first-page":"1","article-title":"Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)","author":"Ipser","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuropharm.2011.07.004","article-title":"Pavlovian fear memory circuits and phenotype models of PTSD","volume":"62","author":"Johnson","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00438-6","article-title":"Acetazolamide: future perspective in topical glaucoma therapeutics","volume":"248","author":"Kaur","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib14","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/npp.2011.311","article-title":"Hippocampal extracellular signal-regulated kinase signaling has a role in passive avoidance memory retrieval induced by GABAA Receptor modulation in mice","volume":"37","author":"Kim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neubiorev.2005.06.005","article-title":"Neural circuits and mechanisms involved in Pavlovian fear conditioning: a critical review","volume":"30","author":"Kim","year":"2006","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.pnpbp.2010.05.015","article-title":"The n-butanolic extract of Opuntia ficus-indica var. saboten enhances long-term memory in the passive avoidance task in mice","volume":"34","author":"Kim","year":"2010","journal-title":"Prog. Neuro-psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrn1825","article-title":"Cognitive neuroscience of emotional memory","volume":"7","author":"LaBar","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1152\/japplphysiol.01572.2005","article-title":"Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness","volume":"102","author":"Leaf","year":"2007","journal-title":"J.\u00a0Appl. Physiol."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0896-6273(01)00433-0","article-title":"A\u00a0role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala","volume":"31","author":"Lin","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0006-8993(87)90811-0","article-title":"Peripheral nerve carbonic anhydrase activity and chronic acetazolamide treatment of rats","volume":"406","author":"Oswald","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11248-011-9520-z","article-title":"Brain phenotype of carbonic anhydrase IX-deficient mice","volume":"21","author":"Pan","year":"2012","journal-title":"Transgenic Res."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/mol.104.005447","article-title":"N-methyl-d-aspartate and brain-derived neurotrophic factor induce distinct profiles of extracellular signal-regulated kinase, mitogen- and stress-activated kinase, and ribosomal s6 kinase phosphorylation in cortical neurons","volume":"67","author":"Rakhit","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/106002809603000515","article-title":"Acetazolamide in the treatment of seizures","volume":"30","author":"Reiss","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200505-807OC","article-title":"Acetazolamide: a treatment for chronic mountain sickness","volume":"172","author":"Richalet","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib25","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1523\/JNEUROSCI.20-21-08177.2000","article-title":"Activation of ERK\/MAP kinase in the amygdala is required for memory consolidation of Pavlovian fear conditioning","volume":"20","author":"Schafe","year":"2000","journal-title":"J.\u00a0Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.neuropharm.2012.11.031_bib26","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.7638623","article-title":"Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors","volume":"269","author":"Staley","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuropharm.2011.06.012","article-title":"Pharmacological treatment of PTSD \u2013 established and new approaches","volume":"62","author":"Steckler","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-6147(02)01899-0","article-title":"Carbonic anhydrase gating of attention: memory therapy and enhancement","volume":"23","author":"Sun","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0022-3565(24)29621-X","article-title":"Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats","volume":"297","author":"Sun","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signalling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.69.5.636","article-title":"Effects of topiramate on cognitive function","volume":"69","author":"Thompson","year":"2000","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib35","series-title":"Micromedex\u00ae 2.0, Eelectronic Version","author":"Thomson Reuters (Healthcare)","year":"2012"},{"key":"10.1016\/j.neuropharm.2012.11.031_bib36","first-page":"206","article-title":"Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial","volume":"249","author":"Vahedi","year":"2002","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib37","first-page":"598","article-title":"Cognitive impairment of acute mountain sickness and acetazolamide","volume":"55","author":"White","year":"1984","journal-title":"Aviat. Space Environ. Med."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib38","doi-asserted-by":"crossref","first-page":"728395","DOI":"10.1155\/2011\/728395","article-title":"Spatial and temporal dynamics in the ionic driving force for GABA(A) receptors","volume":"2011","author":"Wright","year":"2011","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2012.11.031_bib39","doi-asserted-by":"crossref","first-page":"M111","DOI":"10.1074\/mcp.M111.008110","article-title":"Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:38:02Z","timestamp":1745411882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812005783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"alternative-id":["S0028390812005783"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.11.031","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}